Cargando…
Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1)
BACKGROUND: Dengue, caused by one of the four serologically distinct dengue viruses (DENV-1 to − 4), is a mosquito-borne disease of serious global health significance. Reliable and cost-effective diagnostic tests, along with effective vaccines and vector-control strategies, are highly required to re...
Autores principales: | Gelanew, Tesfaye, Hunsperger, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801815/ https://www.ncbi.nlm.nih.gov/pubmed/29409531 http://dx.doi.org/10.1186/s12985-018-0925-7 |
Ejemplares similares
-
Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection
por: Lai, Szu-Chia, et al.
Publicado: (2019) -
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
por: Young, Ellen, et al.
Publicado: (2023) -
Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon
por: Hu, Mingyue, et al.
Publicado: (2023) -
Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
por: Injampa, Subenya, et al.
Publicado: (2017) -
In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2)
por: Panda, Kingshuk, et al.
Publicado: (2021)